Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 7:02 p.m.

    📋 Generation Bio Co. (GBIO) - Financial Results

    Filing Date: 2022-08-04

    Accepted: 2022-08-04 16:26:23

    Event Type: Financial Results

    Event Details:

    Generation Bio (GBIO) Reports Q3 2022 Financial Results Generation Bio (GBIO) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 312204
      • 2M expected to fund operations into 2025 ​​Cambridge, Mass. – Aug. 4, 2022 – Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Earnings Release Balance Sheet Cash Equivalents Marketable Securities 312.20K 312.20K $0.00 +0.00%
    Operating Expenses Loss From Operations -38.48K -38.48K $0.00 +0.00%
    Comprehensive Loss Net Loss -37.93K -37.93K $0.00 +0.00%
    Cash and Marketable Securities 312.20K 312.20K $0.00 +0.00%
    Loss from Operations -38.48K -38.48K $0.00 +0.00%
    Interest Income 552.00 552.00 $0.00 +0.00%
    Net Loss -37.93K -37.93K $0.00 +0.00%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Generation Bio
    • CIK: 0001733294
    • Ticker Symbol: GBIO
    • Period End Date: 2022-08-04
    • Document Type: 8-K

Search

News categories